BMRA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BMRA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-26), Biomerica's current share price is $0.626. Biomerica's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 was $0.76. Biomerica's Cyclically Adjusted PB Ratio for today is 0.82.
The historical rank and industry rank for Biomerica's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Biomerica's highest Cyclically Adjusted PB Ratio was 15.88. The lowest was 0.74. And the median was 3.68.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Biomerica's adjusted book value per share data for the three months ended in Feb. 2024 was $0.464. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.76 for the trailing ten years ended in Feb. 2024.
The historical data trend for Biomerica's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biomerica Quarterly Data | ||||||||||||||||||||
May19 | Aug19 | Nov19 | Feb20 | May20 | Aug20 | Nov20 | Feb21 | May21 | Aug21 | Nov21 | Feb22 | May22 | Aug22 | Nov22 | Feb23 | May23 | Aug23 | Nov23 | Feb24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 3.47 | 1.76 | 1.65 | 1.22 | 1.61 |
For the Medical Devices subindustry, Biomerica's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Biomerica's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Biomerica's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Biomerica's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 0.626 | / | 0.76 | |
= | 0.82 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biomerica's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 is calculated as:
For example, Biomerica's adjusted Book Value per Share data for the three months ended in Feb. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Feb. 2024 (Change) | * | Current CPI (Feb. 2024) |
= | 0.464 | / | 130.9299 | * | 130.9299 | |
= | 0.464 |
Current CPI (Feb. 2024) = 130.9299.
Biomerica Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201405 | 0.784 | 100.373 | 1.023 |
201408 | 0.755 | 100.352 | 0.985 |
201411 | 0.723 | 99.635 | 0.950 |
201502 | 0.708 | 99.032 | 0.936 |
201505 | 0.740 | 100.333 | 0.966 |
201508 | 0.730 | 100.548 | 0.951 |
201511 | 0.721 | 100.135 | 0.943 |
201602 | 0.704 | 100.040 | 0.921 |
201605 | 0.639 | 101.355 | 0.825 |
201608 | 0.632 | 101.617 | 0.814 |
201611 | 0.605 | 101.829 | 0.778 |
201702 | 0.567 | 102.779 | 0.722 |
201705 | 0.527 | 103.256 | 0.668 |
201708 | 0.504 | 103.587 | 0.637 |
201711 | 0.472 | 104.072 | 0.594 |
201802 | 0.464 | 105.052 | 0.578 |
201805 | 0.487 | 106.148 | 0.601 |
201808 | 0.455 | 106.383 | 0.560 |
201811 | 0.475 | 106.338 | 0.585 |
201902 | 0.424 | 106.649 | 0.521 |
201905 | 0.411 | 108.048 | 0.498 |
201908 | 0.371 | 108.245 | 0.449 |
201911 | 0.343 | 108.519 | 0.414 |
202002 | 0.450 | 109.139 | 0.540 |
202005 | 1.208 | 108.175 | 1.462 |
202008 | 1.068 | 109.662 | 1.275 |
202011 | 0.945 | 109.793 | 1.127 |
202102 | 0.862 | 110.968 | 1.017 |
202105 | 0.750 | 113.576 | 0.865 |
202108 | 0.704 | 115.421 | 0.799 |
202111 | 0.701 | 117.269 | 0.783 |
202202 | 0.759 | 119.703 | 0.830 |
202205 | 0.647 | 123.323 | 0.687 |
202208 | 0.621 | 124.958 | 0.651 |
202211 | 0.537 | 125.607 | 0.560 |
202302 | 0.444 | 126.928 | 0.458 |
202305 | 0.697 | 128.314 | 0.711 |
202308 | 0.640 | 129.538 | 0.647 |
202311 | 0.558 | 129.548 | 0.564 |
202402 | 0.464 | 130.930 | 0.464 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Biomerica's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
John P. Kenny | director | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Zacharys Irani | director, officer: Cheif Executive Officer | 17571 VON KARMAN AVE., IRVINE CA 92614 |
Gary Lu | officer: Chief Financial Officer | 12136 AHERN CT, TUSTIN CA 92782 |
Allen Barbieri | director | |
Catherine Coste | director | 966 OCHO RIOS DR, DANVILLE CA 94526 |
David Moatazedi | director | C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008 |
Steven Sloan | officer: Chief Financial Officer | 114 TERRAPIN, IRVINE CA 92618 |
Mark A Sirgo | director | C/O BIODELIVERY SCIENCES INTERNATIONAL, 801 CORPORATE CENTER DRIVE -SUITE 210, RALEIGH NC 27607 |
Francis Cano | director | 11 ACORN LANE, LOS ALTOS CA 94022 |
Francis E Capitanio | officer: President-diagnostics | 1533 MONROVIA AVENUE, NEWPORT BEACH CA 92663 |
Janet Moore | director, 10 percent owner, officer: Secretary | 1533 MUNROVIA AVE, NEWPORT BEACH CA 92663 |
Jane Emerson | director | 1533 MONROVIA AVE, NEWPORT BEACH CA 92663 |
William Snider | other: Greater than 5% holder | 4800 MONTGOMERY LANE, SUITE 230, BETHESDA MD 20814 |
Broadoak Fund The | other: Greater than 5% holder | 7201 WISCONSIN AVE. #630, BETHESDA MD 20814 |
John Roehm | director | 1533 MONROVIA AVE., NEWPORT BEACH CA 92663 |
From GuruFocus
By Marketwired • 10-13-2023
By PurpleRose PurpleRose • 07-13-2022
By GuruFocusNews GuruFocusNews • 07-01-2022
By Stock market mentor Stock market mentor • 01-14-2023
By GlobeNewswire GlobeNewswire • 01-14-2023
By sperokesalga sperokesalga • 05-18-2023
By GuruFocusNews GuruFocusNews • 06-23-2022
By sperokesalga sperokesalga • 06-21-2023
By sperokesalga sperokesalga • 04-14-2023
By Marketwired • 10-13-2023